A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration. Issue 6 (28th May 2019)
- Record Type:
- Journal Article
- Title:
- A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration. Issue 6 (28th May 2019)
- Main Title:
- A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration
- Authors:
- Dell'Aquila, Marco
Gravina, Carmen
Cocomazzi, Alessandra
Capodimonti, Sara
Musarra, Teresa
Sfregola, Stefania
Fiorentino, Vincenzo
Revelli, Luca
Martini, Maurizio
Fadda, Guido
Pantanowitz, Liron
Larocca, Luigi Maria
Rossi, Esther Diana - Abstract:
- Abstract : Background: Hyalinizing trabecular tumors (HTTs) are rare, essentially benign, follicular cell–derived thyroid neoplasms characterized by a trabecular growth pattern and nuclear pseudoinclusions. Their cytological findings are misleading, because these tumors are often misinterpreted on fine needle aspirate cytology as malignant lesions, such as papillary thyroid cancer and/or medullary thyroid cancer, leading to unnecessary total thyroidectomy. The aim of this study was to analyze the cytomorphological features and application of ancillary techniques in a series of HTTs. Methods: Of 26 histological cases of HTT collected from September 2001 to December 2018, 18 cases had concomitant cytopathology. Cytological cases were processed with liquid‐based cytology (LBC). Immunocytochemistry for HBME‐1 and galectine‐3 as well as molecular testing for BRAF V600E mutation were performed on both LBC and histological specimens. Results: The 18 lesions with fine needle aspirate cytology ranged in size from 5 to 45 mm. Cytological diagnoses included: 1 benign lesion favoring goiter (5.5%), 4 atypia of undetermined significance (22.2%), 6 follicular neoplasms (33.3%), 5 suspicious for malignancy favoring papillary thyroid cancer (28%), and 2 malignant (11%). Hence, 89% HTT had a negative concordant immunopanel, and they were 100% wild‐type BRAF V600E . Conclusion: The majority of our HTTs (83.3%) were diagnosed in the indeterminate Bethesda categories, suggesting that theirAbstract : Background: Hyalinizing trabecular tumors (HTTs) are rare, essentially benign, follicular cell–derived thyroid neoplasms characterized by a trabecular growth pattern and nuclear pseudoinclusions. Their cytological findings are misleading, because these tumors are often misinterpreted on fine needle aspirate cytology as malignant lesions, such as papillary thyroid cancer and/or medullary thyroid cancer, leading to unnecessary total thyroidectomy. The aim of this study was to analyze the cytomorphological features and application of ancillary techniques in a series of HTTs. Methods: Of 26 histological cases of HTT collected from September 2001 to December 2018, 18 cases had concomitant cytopathology. Cytological cases were processed with liquid‐based cytology (LBC). Immunocytochemistry for HBME‐1 and galectine‐3 as well as molecular testing for BRAF V600E mutation were performed on both LBC and histological specimens. Results: The 18 lesions with fine needle aspirate cytology ranged in size from 5 to 45 mm. Cytological diagnoses included: 1 benign lesion favoring goiter (5.5%), 4 atypia of undetermined significance (22.2%), 6 follicular neoplasms (33.3%), 5 suspicious for malignancy favoring papillary thyroid cancer (28%), and 2 malignant (11%). Hence, 89% HTT had a negative concordant immunopanel, and they were 100% wild‐type BRAF V600E . Conclusion: The majority of our HTTs (83.3%) were diagnosed in the indeterminate Bethesda categories, suggesting that their cytomorphological features pose issues for reaching a conclusive cytological diagnosis. The ancillary test results in our series support the fact that HTT is a benign neoplasm. Abstract : The cytomorphological features of hyalinizing trabecular tumors (HTTs) pose issues for reaching a conclusive cytological diagnosis. The ancillary test results support the fact that HTT is a benign neoplasm. … (more)
- Is Part Of:
- Cancer cytopathology. Volume 127:Issue 6(2019)
- Journal:
- Cancer cytopathology
- Issue:
- Volume 127:Issue 6(2019)
- Issue Display:
- Volume 127, Issue 6 (2019)
- Year:
- 2019
- Volume:
- 127
- Issue:
- 6
- Issue Sort Value:
- 2019-0127-0006-0000
- Page Start:
- 390
- Page End:
- 398
- Publication Date:
- 2019-05-28
- Subjects:
- BRAF mutation -- hyalinizing trabecular tumor -- immunocytochemistry -- molecular testing -- personalized medicine -- thyroid malignancy -- thyroid nodule
Cancer -- Cytopathology -- Periodicals
Pathology, Cellular -- Periodicals
Cytology -- Technique -- Periodicals
611.01815 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1934-6638 ↗
- DOI:
- 10.1002/cncy.22139 ↗
- Languages:
- English
- ISSNs:
- 1934-662X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library STI - ELD Digital store
- Ingest File:
- 13136.xml